Correlation Between Kineta and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Kineta and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kineta and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kineta Inc and MAIA Biotechnology, you can compare the effects of market volatilities on Kineta and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kineta with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kineta and MAIA Biotechnology.
Diversification Opportunities for Kineta and MAIA Biotechnology
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Kineta and MAIA is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Kineta Inc and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Kineta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kineta Inc are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Kineta i.e., Kineta and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Kineta and MAIA Biotechnology
If you would invest 207.00 in MAIA Biotechnology on October 12, 2024 and sell it today you would earn a total of 5.00 from holding MAIA Biotechnology or generate 2.42% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 5.0% |
Values | Daily Returns |
Kineta Inc vs. MAIA Biotechnology
Performance |
Timeline |
Kineta Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
MAIA Biotechnology |
Kineta and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kineta and MAIA Biotechnology
The main advantage of trading using opposite Kineta and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kineta position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.Kineta vs. Rezolute | Kineta vs. XOMA Corporation | Kineta vs. Protagenic Therapeutics | Kineta vs. Tempest Therapeutics |
MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |